Ecron

Ecron

vecuronium bromide

Manufacturer:

Korea United Pharm

Marketer:

Pharos
Concise Prescribing Info
Contents
Vecuronium Br
Indications/Uses
Adjuvant to anesth to facilitate endotracheal intubation & to provide skeletal muscle relaxation during surgery.
Dosage/Direction for Use
Intubation & subsequent surgical procedures Initially 80-100 mcg/kg IV. Incremental doses: 30-50 mcg/kg IV.
Contraindications
Previous anaphylactic reactions to vecuronium Br.
Special Precautions
Neuromuscular disease, severe obesity; after poliomyelitis. Electrolyte imbalances, dehydration, acidosis. Renal insufficiency & liver disorder, myasthenia gravis.
Adverse Reactions
Anaphylactic reactions.
Drug Interactions
Increased effects w/ anesth, nondepolarizing muscle relaxants, prior administration of suxamethonium, aminoglycoside & polypeptide antibiotics, diuretics, β-blockers, thiamine, MAOIs, quinidine, protamine, imidazole, metronidazole, α-blockers. Decreased effects w/ neostigmine, theophylline.
ATC Classification
M03AC03 - vecuronium ; Belongs to the class of other quaternary ammonium-containing agents used as peripherally-acting muscle relaxants.
Presentation/Packing
Form
Ecron inj 10 mg
Packing/Price
(vial) 1's (Rp181,000/vial)
Form
Ecron inj 4 mg
Packing/Price
1 mL x 10 × 1's (Rp727,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in